Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
01093.HK
CSPC PHARMA (01093.HK): SYS6010 meets primary endpoint in Phase III study for EGFR-mutant NSCLC after EGFR TKI failure
Tags:
CSPC PHARMA
01093.HK
R&D Progress
Clinical Trial
2026-08-26
CSPC PHARMA (01093.HK): Recombinant respiratory syncytial virus vaccine SYS6057 approved for clinical trials in the US
Tags:
CSPC PHARMA
01093.HK
R&D Progress
2026-08-25
CSPC PHARMA(01093.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 6.09 billion, YoY increase of 139.19%
Tags:
CSPC PHARMA
01093.HK
profit growth
2026-08-20
CSPC PHARMA (01093.HK): NDA for KN026 Plus HB1801 as First-Line Treatment for Advanced Breast Cancer Accepted by NMPA
Tags:
CSPC PHARMA
01093.HK
R&D Progress
2026-08-18
CSPC Pharmaceutical Group (01093.HK): Receives US$30 Million Upfront Payment Under siRNA Collaboration Agreement with AstraZeneca
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-08-12
CSPC Pharmaceutical Group (01093.HK): Phase I Clinical Trial of SYS6063 for Relapsed and Refractory Systemic Lupus Erythematosus Initiated at First Study Site in China
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-08-11
CSPC Pharmaceutical Group (01093.HK): Monkeypox mRNA Vaccine SYS6037 Granted US FDA Clinical Trial Approval
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-08-10
CSPC PHARMA(01093.HK): Receives USD10‑Million Milestone Payment from AstraZeneca
Tags:
CSPC PHARMA
01093.HK
AstraZeneca
strategic cooperation
2026-08-05
CSPC PHARMA(01093.HK): Joint Venture Established with AstraZeneca, Holding 51% Stake to Co‑Build Biologics Manufacturing Base
Tags:
CSPC PHARMA
01093.HK
AstraZeneca
joint‑venture company
2026-08-05
CSPC PHARMA(01093.HK): NDA for Neoadjuvant Therapy of Anitumab Combined with HB1801 in HER2‑positive Breast Cancer Accepted and Granted Priority Review
Tags:
CSPC PHARMA
01093.HK
ALPHAMAB-B
New Drug Application
2026-08-04
CSPC PHARMA(01093.HK): Phase Ib/II Clinical Trial of SYS6090 Injection for Colorectal Cancer Initiated at First Study Centre in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-08-03
CSPC Pharmaceutical (01093.HK): SYH2062 Hypertension Phase II Trial Initiated at First China Site; CRB-701 FDA Cleared for Pivotal OPSCC Trial
Tags:
CSPC PHARMA
01093.HK
2026-07-29
CSPC Pharmaceutical (01093.HK): NDA for Sirolimus Albumin-Bound Injection Accepted by NMPA with Breakthrough Therapy and Priority Review Status
Tags:
CSPC PHARMA
01093.HK
2026-07-27
CSPC Pharmaceutical (01093.HK): Paliperidone Palmitate Injection Approved for Marketing; Indicated for Schizophrenia Acute and Maintenance Treatment
Tags:
CSPC PHARMA
01093.HK
2026-07-24
CSPC PHARMA (01093.HK): NDA for Envi Trastuzumab Injection Accepted by NMPA
Tags:
CSPC PHARMA
01093.HK
New Drug Application
2026-07-17
CSPC Pharmaceutical Group (01093.HK): Phase II Clinical Trial of Albumin-bound Sirolimus for Injection Officially Launched
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-07-16
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-07-14
CSPC PHARMA(01093.HK): Phase II Clinical Trial of SYH2070 Injection for Mixed Hyperlipidaemia Initiated at First Clinical Site in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-07-07
CSPC PHARMA(01093.HK): Enters Collaboration, Option and Licence Agreement with AstraZeneca for siRNA Drug Development with USD30 Million Upfront Payment
Tags:
CSPC PHARMA
01093.HK
AstraZeneca
2026-07-02
CSPC Pharmaceutical Group (01093.HK): Phase III Clinical Trial of SYS6010 Combined with Enlimomab as Adjuvant Therapy for NSCLC Officially Launched
Tags:
CSPC Pharmaceutical Group
01093.HK
2026-07-01
Previous
1
2
3
4
Next
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App